Figure 2.

Cancer types and molecular targets reviewed. (A) Bar chart detailing the cancer types reviewed for this study. Colors represent the number of cases profiled by circulating tumor DNA (ctDNA) or tissue sequencing. (B) Bar chart showing the genes identified with a clinical trial or targeted therapy. Colors represent the number of cases for which either a clinical trial or FDA-approved targeted therapy was available. If both a targeted therapy and a clinical trial was matched (N = 9), the patients were colored based on their clinical trial match.